Background: : Macular edema severely reduces Best Corrected Visual Acuity. So, there is a need to reduce the macular thickness for the sake of overcoming the severity of macular edema and improving the visual acuity. For this purpose, Suprachoroidal triamcinolone acetonide is used for reducing the macular thickness.

Objective: The objective of this research is the evaluation of best corrected visual acuity before and after the use of Suprachoroidal triamcinolone acetonide.

Methods: Sixty-two patients were enrolled from the University of Lahore Teaching hospital, Mayo Hospital and Jinnah Hospital Lahore who were suffering with macular edema. The visual acuity of the people were assessed before and after the use of Suprachoroidal triamcinolone acetonide. The comparison is made for highlighting the impact of Suprachoroidal triamcinolone acetonide on the improvement of visual acuity.

Results: 24 (38.7%), 12 (19.4%), and 17 (27.4%) of the respondents visual acuity reduced up to 6/36, 6/24, and 6/18 because of reducing the macular thickness. Meanwhile, 43 (69.4%) and 19 (30.6%) of the people improve their visual acuity up to 6/6 and 6/9 respectively after the use of Suprachoroidal triamcinolone acetonide. The results showed that the use of Suprachoroidal triamcinolone acetonide produced positive consequences for the improvement of visual acuity and reducing the macular thickness.

Conclusion: It is concluded that there is significant improvement in best corrected visual acuity after the use suprachoroidal triamcinolone acetenoide injection that’s why this injection is affective and safer for the treatment of macular edema and for improving visual acuity.

Keywords: Macular edema, Suprachoroidal, Triamcinolone acetonide, Visual acuity, Best corrected visual acuity.